Last edition
News about "Pharmexcil "
Central Bureau of Narcotics (CBN) and Pharmexcil sign an MoU to strengthen regulation of controlled substances in pharma exports through a voluntary industry code of conduct.
Pharmexcil | 26/08/2026 | By News Bureau
India to Build Future-Ready Drug Regulatory Framework: J P Nadda
India will build a future-ready drug regulatory framework, with the Central Drugs Standard Control Organisation (CDSCO) set to launch an end-to-end digital regulatory platform within 18 months.
Pharmexcil | 01/08/2026 | By News Bureau
India-UK FTA to Boost Pharma Exports Beyond USD 981 Million in FY2026-27: Pharmexcil
India-UK FTA is expected to boost India's pharmaceutical exports to the UK beyond USD 981 million in FY2026-27, building on strong export growth, according to Pharmexcil.
Pharmexcil | 16/07/2026 | By News Bureau | 106
Pharmexcil and Department of Commerce Hold Regional Outreach Program in Mumbai
The Department of Commerce hosted a Regional Outreach Program and press interaction at Pharmexcil’s Mumbai office, highlighting the growth and achievements of India’s pharmaceutical exports over the past 12 years.
Pharmexcil | 11/06/2026 | By News Bureau
PHARMEXCIL Engages Government Leaders to Strengthen Indian Pharmaceutical Export Growth
The Pharmaceuticals Export Promotion Council of India (PHARMEXCIL) held a series of high-level discussions with key government stakeholders to align policy priorities, accelerate export momentum and reinforce India’s position in global pharmaceutical markets.
Pharmexcil | 06/01/2026 | By News Bureau | 408
India’s pharmaceutical export industry is preparing for 2026 with a sharp focus on quality excellence, regulatory compliance and diversification into new global markets, according to the Pharmaceuticals Export Promotion Council of India (Pharmexcil).
Pharmexcil | 02/01/2026 | By Darshana | 389
Pharmexcil Calls for GST Parity on APIs and Formulations to Boost Pharma Efficiency
The Pharmaceuticals Export Promotion Council of India (Pharmexcil) has called for harmonising GST rates on both active pharmaceutical ingredients (APIs) and finished formulations to streamline compliance and ease financial strain.
Pharmexcil | 26/08/2025 | By Darshana | 387
Pharmexcil, USP Discuss Collaboration on Biosimilar Accessibility, Building Resilient Supply Chain
This discussion between Pharmaceuticals Export Promotion Council of India (Pharmexcil) and United States Pharmacopoeia (USP) happened during the United States Pharmacopoeial (USP) Convention-2025 held recently, which brought together representatives from across the health and science ecosystem to launch the 2025–2030 cycle.
Pharmexcil | 30/06/2025 | By Darshana | 239
Pharmexcil Appoints Two Advisors for Streamlining Regulatory Support for Exporters
The initiative, spearheaded by Pharmexcil chairman Namit Joshi and vice chairman Bhavin Mehta, is part of a broader agenda to streamline the export operations and help update on evolving trade regulations.
Pharmexcil | 26/06/2025 | By Darshana | 241
Bhavin Mukund Mehta Joins Pharmexcil as its Vice-Chairman
Mehta, an industry veteran with over 25 years of experience, has been instrumental in expanding Kilitch Drugs’ presence in international markets while strengthening its foothold in India.
Pharmexcil | 05/02/2025 | By Aishwarya | 683
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy